Efficacy of therapy in patients with newly diagnosed myelodysplastic syndrome with unfavorable immunophenotypic and cytogenetic prognosis
Открыть
Дата
2023Автор
Trubkina, H.
Iskrou, I.
Lendzina, I.
Lebedeva, T.
Smolnikova, V.
Metadata
Показать полную информациюБиблиографическое описание
Efficacy of therapy in patients with newly diagnosed myelodysplastic syndrome with unfavorable immunophenotypic and cytogenetic prognosis / H. Trubkina, I. Iskrou, I. Lendzina [et al.] // HemaSphere. – 2023. – Vol. 7, suppl. 3 [EHA 2023 : 28th Hybrid Congr. of the Europ. Hematology Assoc., Frankfurt, 8-15 June 2023 : Abstr. book]. – P. 3901–3902. – URL: https://journals.lww.com/hemasphere/Documents/EHA2023%20Abstract%20Book.pdf